218 related articles for article (PubMed ID: 32366012)
1. An Overview of the Potential Use of Ethno-Medicinal Plants Targeting the Renin-Angiotensin System in the Treatment of Hypertension.
De Lange-Jacobs P; Shaikh-Kader A; Thomas B; Nyakudya TT
Molecules; 2020 Apr; 25(9):. PubMed ID: 32366012
[TBL] [Abstract][Full Text] [Related]
2. Phytotherapy of Hypertension: An Updated Overview.
Ajebli M; Eddouks M
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):812-839. PubMed ID: 31880255
[TBL] [Abstract][Full Text] [Related]
3. Three key proteases--angiotensin-I-converting enzyme (ACE), ACE2 and renin--within and beyond the renin-angiotensin system.
Guang C; Phillips RD; Jiang B; Milani F
Arch Cardiovasc Dis; 2012; 105(6-7):373-85. PubMed ID: 22800722
[TBL] [Abstract][Full Text] [Related]
4. Are we poised to target ACE2 for the next generation of antihypertensives?
Ferreira AJ; Raizada MK
J Mol Med (Berl); 2008 Jun; 86(6):685-90. PubMed ID: 18449520
[TBL] [Abstract][Full Text] [Related]
5. Targeting the vasoprotective axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy.
Bradford CN; Ely DR; Raizada MK
Curr Hypertens Rep; 2010 Aug; 12(4):212-9. PubMed ID: 20556668
[TBL] [Abstract][Full Text] [Related]
6. Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.
Fraga-Silva RA; Ferreira AJ; Dos Santos RA
Curr Hypertens Rep; 2013 Feb; 15(1):31-8. PubMed ID: 23212695
[TBL] [Abstract][Full Text] [Related]
7. New drug targets for hypertension: A literature review.
Gao Q; Xu L; Cai J
Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166037. PubMed ID: 33309796
[TBL] [Abstract][Full Text] [Related]
8. ACE2: A novel therapeutic target for cardiovascular diseases.
Der Sarkissian S; Huentelman MJ; Stewart J; Katovich MJ; Raizada MK
Prog Biophys Mol Biol; 2006; 91(1-2):163-98. PubMed ID: 16009403
[TBL] [Abstract][Full Text] [Related]
9. Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.
Xia H; Sriramula S; Chhabra KH; Lazartigues E
Circ Res; 2013 Oct; 113(9):1087-1096. PubMed ID: 24014829
[TBL] [Abstract][Full Text] [Related]
10. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
12. Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.
Ali Q; Wu Y; Hussain T
Kidney Int; 2013 Nov; 84(5):931-9. PubMed ID: 23823602
[TBL] [Abstract][Full Text] [Related]
13. The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challenges.
Mendoza A; Lazartigues E
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):201-8. PubMed ID: 25801471
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effect of caffeic acid and its analogs through dual renin-angiotensin-aldosterone system inhibition.
Bhullar KS; Lassalle-Claux G; Touaibia M; Rupasinghe HP
Eur J Pharmacol; 2014 May; 730():125-32. PubMed ID: 24631256
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin I-converting enzyme levels and renin-aldosterone axis recovery after cessation of chronic licorice ingestion.
Megia A; Herranz L; Martin-Almendra MA; Martinez I
Nephron; 1993; 65(2):329-30. PubMed ID: 8247207
[No Abstract] [Full Text] [Related]
16. Angiotensin-converting enzyme 2 in human plasma and lung tissue.
Xie J; Huang QF; Zhang Z; Dong Y; Xu H; Cao Y; Sheng CS; Li Y; Wang C; Wang X; Wang JG
Blood Press; 2023 Dec; 32(1):6-15. PubMed ID: 36495008
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
Hu Y; Liu L; Lu X
Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
Aleksova A; Ferro F; Gagno G; Cappelletto C; Santon D; Rossi M; Ippolito G; Zumla A; Beltrami AP; Sinagra G
J Intern Med; 2020 Oct; 288(4):410-421. PubMed ID: 32459372
[TBL] [Abstract][Full Text] [Related]
19. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
20. The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases.
Lazartigues E; Feng Y; Lavoie JL
Curr Pharm Des; 2007; 13(12):1231-45. PubMed ID: 17504232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
